Glaxosmithkline Pharmaceuticals informs about board meeting

15 Jan 2025 Evaluate
Glaxosmithkline Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 10/02/2025 to consider and approve Un Audited financial results for quarter and nine months ended 31st December 2024.

The above information is a part of company’s filings submitted to BSE.

Glaxosmithkline Phar Share Price

2426.40 18.85 (0.78%)
02-Feb-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1628.90
Dr. Reddys Lab 1182.35
Cipla 1311.75
Zydus Lifesciences 879.25
Lupin 2128.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×